Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combined Corticosteroid and Long‐acting Beta2‐agonist in One Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434208/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease.
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434208/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease. Accessed October 6, 2026.
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. (2026). In Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434208/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease
Combined Corticosteroid and Long‐acting Beta2‐agonist in One Inhaler Versus Placebo for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 October 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434208/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
ID - 434208
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434208/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_placebo_for_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

